GTI 2040
GTI-2040, a 20-mer phosphorothioate oligonucleotide, was designed to hybridize to the mRNA sequence of human ribonucleotide reductase R2. GTI-2040 has been shown to inhibit human cancer cell proliferation by downregulation of R2 expression in vitro and to significantly inhibit tumor growth in xenograft models of human cancer in mice.
Product Specifications
CAS Number
236391-66-5
UNSPSC
12352208
Target
DNA/RNA Synthesis
Type
Oligonucleotides
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/gti-2040.html
Solubility
10 mM in H2O
Smiles
[GTI2040]
References & Citations
[1]Vassilakos A, Lee Y, Viau S, et al. GTI-2040 displays cooperative anti-tumor activity when combined with interferon alpha against human renal carcinoma xenografts. Int J Oncol. 2009;34 (1) :33-42.|[2]Ferdinandi ES, Vassilakos A, Lee Y, et al. Preclinical toxicity and toxicokinetics of GTI-2040, a phosphorothioate oligonucleotide targeting ribonucleotide reductase R2. Cancer Chemother Pharmacol. 2011;68 (1) :193-205. doi:10.1007/s00280-010-1473-z
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR10395164 96 Well
Human Agouti signaling protein (ASIP) ELISA kit
Sign In for Pricing
View Details 
250717 100 µg
PTTG1 (Pituitary Tumor-Transforming 1, EAP1, HPTTG, MGC126883, MGC138276, PTTG, TUTR1)
Sign In for Pricing
View Details